• Gentamicin, Peak, Serum
  • Bone Morphogenetic Protein Receptor Type II (BMPR2) Gene Mutation Analysis
  • Cyclic Citrullinated Peptide (CCP) Antibody, IgG
  • Prostate Specific Antigen (PSA), Total
  • Protein Immunofixation Electrophoresis, CSF
  • Bacterial Culture, Blood
  • Obstetric Panel
  • BLM Gene (Bloom’s Syndrome) Mutation Analysis
  • MDA, Urine
  • Lorazepam, Serum
  • LDS
  • Sign up
  • Log in
  • LDS
  • /Medical Tests
  • /UBE3A Gene Mutation Analysis, Angelman Syndrome, Tissue
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References

UBE3A Gene Mutation Analysis, Angelman Syndrome, Tissue
Medical Test

LOINC
Access to UBE3A Gene Mutation Analysis, Angelman Syndrome, Tissue is restricted.
Loading...